NASDAQ:BMGL

Basel Medical Group Ordinary Shares Stock Forecast

etoro logo Buy BMGL
*Your capital is at risk
$4.90
-0.87 (-15.08%)
At Close: Aug 10, 2026

Should you buy BMGL stock?

Last updated:

Based on market data through , StockInvest.us rates Basel Medical Group Ltd Ordinary Shares (BMGL) as a Strong Sell Candidate with a technical score of -6.93 on its -10 to +10 scale. This is a downgrade from Sell in the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 18.06%
  • 3-month trend forecast Down 26.15%
  • Strong Sell Candidate -6.93
AI Analysis AI Analysis of BMGL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BMGL to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Is Basel Medical Group Ltd Ordinary Shares stock still a buy after falling -15.08% on Monday?
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 29, 2026 Loss -18.06%

The Basel Medical Group Ltd Ordinary Shares stock price fell by -15.08% on the last day (Monday, 10th Aug 2026) from $5.77 to $4.90. During the last trading day the stock fluctuated 7.68% from a day low at $4.82 to a day high of $5.19. The price has fallen in 6 of the last 10 days and is down by -16.52% for this period. Volume has increased on the last day by 6 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 thousand shares were bought and sold for approximately $28.29 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -26.15% during the next 3 months and, with a 90% probability hold a price between $2.91 and $5.41 at the end of this 3-month period.

BMGL Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Basel Medical Group Ltd Ordinary Shares stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.59 and $6.28. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 14, 2026, and so far it has fallen -39.66%. Further fall is indicated until a new bottom pivot has been found. Basel Medical Group Ltd Ordinary Shares gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Basel Medical Group Ltd Ordinary Shares stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.370 between high and low, or 7.68%. For the last week, the stock has had daily average volatility of 9.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BMGL) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Basel Medical Group Ltd Ordinary Shares to open at $4.97, and during the day (based on 14 day Average True Range), to move between $4.54 and $5.26, which gives a possible trading interval of +/-$0.720 (+/-15.86%) up or down from last closing price. If Basel Medical Group Ltd Ordinary Shares takes out the full calculated possible swing range there will be an estimated 15.86% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $5.60, some $0.700 (14.29%) from the current price of $4.90, our system finds the risk reward not very attractive.

Is Basel Medical Group Ltd Ordinary Shares stock A Buy?

Basel Medical Group Ltd Ordinary Shares holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.929 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $4.97 ( 1.43%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BMGL Performance

Trading levels for BMGL

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 5.34 8.98%
R2 5.20 6.10%
R1 5.11 4.31%
Price 4.90
S1 4.83 -1.46%
S2 4.74 -3.24%
S3 4.60 -6.12%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.99 22.24%
R2 5.82 18.78%
R1 5.60 14.29%
Price 4.90
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Basel Medical Group Ltd Ordinary Shares Stock and on which exchange is it traded?
The symbol for Basel Medical Group Ltd Ordinary Shares is BMGL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Basel Medical Group Ltd Ordinary Shares Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Basel Medical Group Ltd Ordinary Shares (BMGL) as a Strong Sell Candidate with a technical score of -6.93 on its -10 to +10 scale. This is a downgrade from Sell in the previous daily evaluation. Since the Sell signal began on Jul 29, 2026, the price has fallen 18.06%. The current 3-month trend forecast projects a fall of 26.15%.

How to buy Basel Medical Group Ltd Ordinary Shares Stock?
Basel Medical Group Ltd Ordinary Shares Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Basel Medical Group Ltd Ordinary Shares Stock.

What's the current price of Basel Medical Group Ltd Ordinary Shares Stock?
As of the end of day on the Aug 10, 2026, the price of an Basel Medical Group Ltd Ordinary Shares (BMGL) share was $4.90.

What is the 52-week high and low for Basel Medical Group Ltd Ordinary Shares Stock?
The 52-week high for Basel Medical Group Ltd Ordinary Shares Stock is $26.40 and the 52-week low is $4.60.

What is the market capitalization of Basel Medical Group Ltd Ordinary Shares Stock?
As of the Aug 10, 2026, the market capitalization of Basel Medical Group Ltd Ordinary Shares is 7.671M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE